Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 74126

2 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
May 10, 2016
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Allergan Sales, LLC

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

2 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 2

Tazorac (tazarotene) Gel 0.05%, Rx only, packaged in a) 30g (NDC 0023-8335-03) and b) 100g (NDC 0023-8335-10) tubes, Allergan Inc, Irvine, CA 92612

D-1064-2016
Recall number
D-1064-2016
Initiated
May 10, 2016
Classification
Class II
Status
Terminated
Recalling firm
Allergan Sales, LLC
Quantity
17802 units

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Failed Content Uniformity Specifications

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed Content Uniformity Specifications.

Code information

Lot #: a) 84172, b) 84173, Exp FEB/2017

Distribution pattern

Nationwide and Puerto Rico

drug · product 2 of 2

Tazorac (tazarotene) Gel 0.05%, 15 x 3.5g, sample packs, Allergan Inc, Irvine, CA 92612. UPC 300238335159

D-1065-2016
Recall number
D-1065-2016
Initiated
May 10, 2016
Classification
Class II
Status
Terminated
Recalling firm
Allergan Sales, LLC
Quantity
N/A

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Failed Content Uniformity Specifications

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed Content Uniformity Specifications.

Code information

Lot #: 84126, Exp FEB/2017

Distribution pattern

Nationwide and Puerto Rico